Among the most contentious issues in modern healthcare is the role of medical interventions for transgender youth—particularly the use of puberty blockers and hormone therapy for those under 18.
The science and policy of minimising risks associated with substance use, high-risk behaviours, and public health challenges — grounded in evidence rather than stigma.
